2013•Medical Innovation of ChinaRequires access

Effect Observation of Glucocorticoid Inhalation on Stabilized Patients with Chronic Pulmonary Disease

Wei Yan-ping

Open publisher page 0 citations

Abstract

Objective:To probe into the clinical effect of ICSs budesonide on stabilized patients with chronic pulmonary disease.Method: Clinical data of 86 stabilized patients with COPD were analyzed retrospectively.86 cases were divided into observation group(44 cases)and control group (42 cases).The control group were given routine treatment.ICSs budesonide was added to treat patients of observation group,on the basis of routine treatment.Result:The number of inpatients resulting from acute exacerbation in observation group was obviously less than that of control group,two groups compared with a statistically significant difference(P 0.05);all observational indices of two groups after treatment were better than those before treatment(P 0.05).However,the improved degree of observation group was better than that of control group.The differences between two groups had a statistically significant(P 0.05).Conclusion:ICSs has significant effect on stabilized patients with COPD.It can effectively slow the decline in lung function and improve symptoms to reduce the number of patients with acute exacerbation.Therefore,it is worthy of clinical promotion.

About this research paper

What this paper is about

Objective:To probe into the clinical effect of ICSs budesonide on stabilized patients with chronic pulmonary disease.Method: Clinical data of 86 stabilized patients with COPD were analyzed retrospectively.86 cases were divided into observation group(44 cases)and control group (42 cases).The control group were given routine treatment.ICSs budesonide was added to treat patients of observation group,on the basis of routine treatment.Result:The number of inpatients resulting from acute exacerbation in observation group was obviously less than that of control group,two groups compared with a statistically significant difference(P 0.05);all observational indices of two groups after treatment were better than those before treatment(P 0.05).However,the improved degree of observation group was better than that of control group.The differences between two groups had a statistically significant(P 0.05).Conclusion:ICSs has significant effect on stabilized patients with COPD.It can effectively slow the decline in lung function and improve symptoms to reduce the number of patients with acute exacerbation.Therefore,it is worthy of clinical promotion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To probe into the clinical effect of ICSs budesonide on stabilized patients with chronic pulmonary disease.Method: Clinical data of 86 stabilized patients with COPD were analyzed retrospectively.86 cases were divided into observation group(44 cases)and control group (42 cases).The control group were given routine treatment.ICSs budesonide was added to treat patients of observation group,on the basis of routine treatment.Result:The number of inpatients resulting from acute exacerbation in observation group was obviously less than that of control group,two groups compared with a statistically significant difference(P 0.05);all observational indices of two groups after treatment were better than those before treatment(P 0.05).However,the improved degree of observation group was better than that of control group.The differences between two groups had a statistically significant(P 0.05).Conclusion:ICSs has significant effect on stabilized patients with COPD.It can effectively slow the decline in lung function and improve symptoms to reduce the number of patients with acute exacerbation.Therefore,it is worthy of clinical promotion.

Key concepts: Medicine, Budesonide, Exacerbation, COPD, Internal medicine, Pulmonary function testing, Pulmonary disease, Inhalation

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect Observation of Glucocorticoid Inhalation on Stabilized Patients with Chronic Pulmonary Disease — Research Paper | ScholarLens